gip/glp-1 agonists Potential Use of GLP-1 and Receptor for Respiratory Disorders: Where Are We at? 🔴Comparison of GLP-1R Mono-Agonist vs.

A study of nearly 1.1 million people found that semaglutide (the drug in Ozempic and Wegovy) was associated with a 40-70% lower risk of developing Alzheimer's compared to other diabetes medications

We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)

Experts say theres no evidence GLP-1s can be absorbed through the skin and these patches dont contain the FDA-approved medicine anyway.

Berberine patches reviewed: what science says about effectiveness, how they compare to oral supplements, side effects, and safety guidance.

Remove patch and discard

Evidence-based insights for patients and providers.